MONOCLONAL ANTIBODY, WHICH HAS IMMUNOSUPRESSIVE ACTIVITY, OR ITS ANTIGEN-BINDING FRAGMENT Russian patent published in 2015 - IPC C07K16/18 

Abstract RU 2559550 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to biochemistry. Described is monoclonal antibody or its antigen-binding fragment with very high immunosuppressive activity, which binds with peptide, which contains amino acid succession SSVLYGGPPSAA, or with conjugate of said peptide with pharmaceutically acceptable carrier, where monoclonal antibody or its antigen-binding fragment has higher affinity of binding with core histone, than with H1 histone. Also described are methods of treatment and reduction of risk of transplant rejection development, which include introduction of effective quantity of described antibody or its antigen-binding fragment.

EFFECT: invention extends arsenal of immunosuppressive medications.

12 cl, 6 dwg, 4 ex

Similar patents RU2559550C2

Title Year Author Number
TUMOUR-TARGETED MONOCLONAL ANTIBODIES AGAINST FZD10 AND THEIR APPLICATION 2006
  • Nakamura Jusuke
  • Katagiri Tojomasa
  • Nakatsuru Suiti
  • Ehndo Kejgo
RU2412203C2
ANTIBODY BOUND WITH CARBONIC ANHYDRASE, AND USE THEREOF 2017
  • Moon Yoo Ri
  • Yoon Sangsoon
  • Hong Jeong Won
  • Kim Eun Jung
  • Choi Da Bin
RU2727682C1
MONOCLONAL ANTIBODIES AGAINST INTERFERON-ALPHA AND APPLICATION METHODS 2006
  • Banshero Zhak
  • Prilliman Kajli
  • Paskual Virkhinija
  • Palukka Anna Karolina
RU2431638C2
ANTIBODIES TO CANINE PD-1 2014
  • Morsey, Mohamad
  • Zhang, Yuanzheng
  • Bartels-Morozov, Denise
  • Erskine, Jason
  • Tarpey, Ian
RU2761663C2
METHOD FOR CANCER DETECTION 2013
  • Ido Takaesi
  • Okano Fumiesi
RU2646466C2
ANTI-PDL-1 ANTIBODY, ITS PHARMACEUTICAL COMPOSITION AND USE 2017
  • Li, Baiyong
  • Xue, Tongtong
  • Xia, Yu
  • Wang, Zhongmin Maxwell
  • Xiao, Liang
  • Wang, Lichun
  • Wang, Jingyi
RU2693661C2
HUMANISED ANTIBODY AND ANTIGENBINDING FRAGMENT (Fab), WHICH BINDS WITH HUMAN INTERFERON-γ, DNA FRAGMENTS CODING CLAIMED ANTIBODY AND ANTIGEN-BINDING FRAGMENT, CELL, TRANSFORMED BY DNA FRAGMENT, AND METHOD OF OBTAINING CLAIMED ANTIBODY AND ANTIGEN-BINDING FRAGMENT 2013
  • Aliev Tejmur Kantamirovich
  • Dolgikh Dmitrij Aleksandrovich
  • Kirpichnikov Mikhail Petrovich
  • Larina Marija Viktorovna
  • Pozdnjakova Ljubov' Petrovna
  • Sveshnikov Petr Georgievich
  • Solopova Ol'Ga Nikolaevna
RU2539752C2
ANTISUBSTANCES AGAINST GLOBULOMER Aβ, THEIR ANTIGEN-BINDING PARTS, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, WAYS OF PRODUCTION OF MENTIONED ANTISUBSTANCES, COMPOSITIONS CONTAINING MENTIONED ANTISUBSTANCES, APPLICATION OF MENTIONED ANTISUBSTANCES AND WAYS OF APPLICATION OF MENTIONED ANTISUBSTANCES 2006
  • Bargkhorn Shtefan
  • Ehbert Ul'Rikh
  • Khillen Khajnts
  • Keller Patrik
  • Shtribinger Andreas
  • Labkovskij Boris
RU2442793C2
ADVANCED GLYCATION END PRODUCT (RAGE) RECEPTOR ANTIBODIES AND USING THEM 2009
  • Gu Tszitsze
  • Siekh Chun-Min
  • U Chzhehn'
  • Didzhammarino Ehnriko L.
  • Lo Fyn
  • Foks Dzherard B.
  • Kharlan Dzhon E.
  • Shmidt Martin
  • Lebbert Ral'F
  • Mjuller Rajnkhol'D
  • Ehbert Ul'Rikh
  • Nimmrikh Fol'Ker
RU2518351C2
METHOD FOR CANCER DETECTION 2013
  • Ido Takaesi
  • Okano Fumiesi
RU2646464C2

RU 2 559 550 C2

Authors

Sato Sudzi

Goto Takeshi

Goto Sigeru

Nakano Tosiaki

Okhmori Naoja

Tiang Kueiten

Simada Jaei

Mori Kendzi

Mijagi Takamitsu

Dates

2015-08-10Published

2011-08-19Filed